Drug Nomenclature
Drug Regulation
Bioequivalence studies: Biowaivers
Drug Products: Biologics, Biosimilars and Interchangeables
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Prescription, Nonprescription and Orphan Drugs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 9, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Maryll Toufanian1, John R Peters1, Kathleen Uhl1
1Center for Drug Evaluation and Research, Office of Generic Drugs, US Food and Drug Administration, Silver Spring, Maryland.
No abstract available in PubMed .